You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phosphoinositide-3 Kinase Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)

Recruiting
  • Activated PI3K-delta Syndrome
  • Immunodeficiency Primary
  • Shanghai, Shanghai, China
  • +1 more
Mar 21, 2022

HR+, HER2-, Advanced Breast Cancer Trial (alpelisib)

Available
  • HR+, HER2-, Advanced Breast Cancer
  • (no location specified)
Jul 5, 2022

Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,

Not yet recruiting
  • Solid Tumors, Adult
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Jul 21, 2022

APDS Trial in Netherlands, United States (Leniolisib)

Not yet recruiting
  • APDS
  • Los Angeles, California
  • +4 more
Jan 12, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jul 28, 2023

APDS Trial in France, Netherlands, United States (Leniolisib)

Not yet recruiting
  • APDS
  • Los Angeles, California
  • +3 more
Jul 8, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)

Recruiting
  • Non Small Cell Lung Cancer
  • Metformin Hydrochloride
  • Placebo
  • Mexico City, Mexico
    Instituto Nacional de Cancerologia
Jul 21, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Colorectal Cancer, Gastric Cancer, HER2-negative Breast Cancer Trial (TOS-358)

Not yet recruiting
  • Colorectal Cancer
  • +8 more
  • (no location specified)
Jan 5, 2023

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Healthy Trial in Nottingham ([14C]-Paxalisib Capsule)

Active, not recruiting
  • Healthy
  • [14C]-Paxalisib Capsule
  • Nottingham, United Kingdom
    Quotient Sciences
Aug 16, 2022

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia
    • London, London, City Of, United Kingdom
    • +9 more
    Jan 13, 2023

    Activated PI3Kdelta Syndrome (APDS); PASLI Disease Trial in Worldwide (CDZ173)

    Active, not recruiting
    • Activated PI3Kdelta Syndrome (APDS); PASLI Disease
    • Bethesda, Maryland
    • +7 more
    Jul 22, 2022

    Follicular Lymphoma Trial in New York (TGR-1202)

    Terminated
    Has Results
    • Follicular Lymphoma
    • New York, New York
      Columbia University Medical Center
    Jun 28, 2021

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +14 more
    • Biopsy
    • +25 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +170 more
    Jan 30, 2023

    Acneiform Eruptions, Cancer, Treatment-Related Trial in Montreal (Doxycycline 100mg po once daily x 6 months, Isotretinoin 40 mg

    Recruiting
    • Acneiform Eruptions
    • Cancer, Treatment-Related
    • Doxycycline 100mg po once daily x 6 months
    • Isotretinoin 40 mg po once daily x 6 months
    • Montreal, Quebec, Canada
      Jewish General Hospital
    Aug 31, 2021

    Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Nivolumab
    • Relatlimab
    • Ciudad de Buenos Aires, Buenos Aires, Argentina
    • +74 more
    Nov 11, 2022

    Previously Treated PH + CML Trial in Worldwide (Bosutinib)

    Terminated
    Has Results
    • Previously Treated PH + CML
    • Los Angeles, California
    • +47 more
    Dec 2, 2021

    Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

    Not yet recruiting
    • Liver Transplant; Complications
    • +3 more
    • multi-kinase inhibitors in combination with bevacizumab
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Sep 11, 2023

    Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

    Recruiting
    • Chronic Myelogenous Leukemia
    • ABL001 40mg BID
    • +2 more
    • Caba, Buenos Aires, Argentina
    • +53 more
    Jan 27, 2023

    Safety Issues, Efficacy, Self Trial in Beijing (TQB3525)

    Active, not recruiting
    • Safety Issues
    • Efficacy, Self
    • Beijing, China
      Peking University Shougang Hospital
    Dec 29, 2020

    Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))

    Not yet recruiting
    • Atrial Fibrillation
    • Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
    • Caen, Normandie, France
      Caen University Hospital, Department of Pharmacology
    Sep 6, 2023